Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Feb 15, 2015

Pharma R&D Activities May Get Tax Boost in Budget

Annually, India exports pharmaceutical products worth $10 billion.

Pharma R&D Activities May Get Tax Boost in Budget

New Delhi: Finance Minister Arun Jaitley may accord enhanced tax incentives for research and development (R&D) activities in the pharmaceutical sector in the forthcoming Budget to be announced on February 28.

In its Budget proposals, the Commerce Ministry has sought "weighted average tax benefit of 400 per cent for R&D activities for the sector", a senior official told PTI.

"There is an urgent need to boost R&D in the pharma sector. India is the hub of generic medicines. It contributes significantly to the country's total exports," the official added.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

Annually, India exports pharmaceutical products worth $10 billion. The market size of the industry is around Rs 1 lakh crore.

The need for special financial package for the pharma sector has been highlighted in various fora.

The pharma sector is a capital intensive sector. Besides R&D expenditure, regulatory requirements require large funds, an industry expert said.

"All quality investments should be treated on par with R&D to provide incentives to the industry," the official added.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Listen to the latest songs, only on JioSaavn.com